News

Russia agency has developed COVID-19 treatment based on anti-malaria drug backing Trump narrative Chloroquine can treat coronavirus

A Russian agency, Federal Biomedical says it has developed a drug that can treat copid-19.

The agency says it has developed adrug based on mefloquine which has been used for the treatment of malaria.

According to the agency’s statement, the drug prevents virus replication in cells and as a result, stops the inflammatory process caused by the virus.

Veronika Skvortsova, the agency’s head, said Mefloquine has to be combined with antibiotics for the maximum effect, allowing an increase in the concentration of antiviral agents in blood plasma and lungs.

“This will ensure effective treatment of patients with various degrees of coronavirus infection,” Skvortsova said.

The agency said it was developing an effective and safe scheme for the prevention of coronavirus on the basis of mefloquine.

The treatment was developed taking Chinese and French experience into account, it added.

COVID-19 treatment, for now, focuses on relieving symptoms such as breathing assistance.

Companies around the world are racing to develop vaccines. A few have launched early safety testing in humans, but experts say it could take a year or more to develop and test a vaccine.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button